Illumina: Accelerating the access to liquid biopsy for clinical trials

September 10, 15.00 CET | Online

Join our mini webinar on accelerating the access to liquid biopsy for clinical trials “Need for Easy Testing: How to deliver precision medicines faster by using liquid biopsy”

Cancer patients’ need innovative medicines and testing methods more than ever. We are actively working with the scientific community to enable new technologies to detect and monitor a patient’s cancer with a simple blood test. By combining Illumina’s technical ingenuity with CeGaT quality analysis at scale, we want to create a world where we can provide crucial early disease data to get patients that need it into accelerated care.